Author's Response:

Abstract

In their review of our article, Drs. Schwartz and Reardon expressed concern that the cost-effectiveness model that we used in our calculations did not reflect typical clinical practices in the treatment of glaucoma. They did not provide a reference for this assertion and their definition of typical clinical practice is unclear. In our article, however, we describe how the treatment algorithm used was developed by a panel of eight glaucoma experts14 and how the specific parameters were based on published recommendations for target pressure ranges, patient monitoring, and adjunctive therapy.